{
  "id": 4081965,
  "title": "Precigen director Jeffrey Kindler sells $1.38m in stock",
  "url": "https://urgent.news/2026/08/29/precigen-director-jeffrey-kindler-sells-1-38m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-29T01:45:49.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/precigen-director-jeffrey-kindler-sells-138m-in-stock-93CH-4881915"
  },
  "original_language": "en",
  "account": "Precigen director Jeffrey Kindler sold 185,000 shares of the company's stock on August 26, 2026, for a total of $1.38 million. The sale occurred at prices between $7.38 and $7.59 per share, with an average price of $7.44. Kindler now owns 17,100 shares of Precigen common stock. The company's shares are currently trading at $6.95, near its 52-week high of $7.71, following a 83% increase over the past six months. Analysts consider the stock to be undervalued, with a Fair Value of $7.46. Precigen's second-quarter results exceeded expectations, with earnings of $0.05 per share, surpassing the anticipated loss of $0.01. Revenue surged to $54.98 million, nearly double the projected $27.83 million, driven by strong demand for their therapy PAPZIMEOS for adult recurrent respiratory papillomatosis.",
  "summary": null,
  "key_points": [
    "Jeffrey Kindler sold 185,000 shares of Precigen for $1.38 million on August 26, 2026.",
    "Shares traded at $7.44 on average during the sale, between $7.38 and $7.59.",
    "Precigen's stock is near its 52-week high of $7.71, with analysts considering it undervalued."
  ],
  "editors_take": "The sale of $1.38 million in Precigen stock by director Jeffrey Kindler comes as the company's shares trade near a 52-week high and analysts consider the stock undervalued.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}